These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481 [TBL] [Abstract][Full Text] [Related]
8. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Singh P; Taylor RH; Colin-Jones DG Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643 [TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus occurring as a complication of scleroderma. Cameron AJ; Payne WS Mayo Clin Proc; 1978 Sep; 53(9):612-5. PubMed ID: 682690 [TBL] [Abstract][Full Text] [Related]
10. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900 [TBL] [Abstract][Full Text] [Related]
11. Pepsinogens in epithelium of Barrett's esophagus. Mangla JC; Kim Y; Guarasci G; Schenk EA Gastroenterology; 1973 Dec; 65(6):949-55. PubMed ID: 4753353 [No Abstract] [Full Text] [Related]
12. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro. De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793 [TBL] [Abstract][Full Text] [Related]
16. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
17. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656 [TBL] [Abstract][Full Text] [Related]
18. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Giovannini M; Bories E; Pesenti C; Moutardier V; Monges G; Danisi C; Lelong B; Delpero JR Endoscopy; 2004 Sep; 36(9):782-7. PubMed ID: 15326573 [TBL] [Abstract][Full Text] [Related]
19. [Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia]. Catrambone G; Leoncini G; Iurilli L; Queirolo A; Spinelli A; Taviani M; Mazzarino S Minerva Chir; 1999 Oct; 54(10):657-67. PubMed ID: 10575887 [TBL] [Abstract][Full Text] [Related]
20. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]